抑郁症药物
Search documents
道指开盘涨0.04%,标普500跌0.01%,纳指跌0.01%
Xin Lang Cai Jing· 2025-12-31 14:44
Group 1 - Nike shares increased by 2.6% as company insiders made significant stock purchases towards the end of the year [1] - Trump Media Technology Group saw a rise of 3.2% with plans to distribute digital tokens to shareholders [1] - Axsome Therapeutics shares rose by 5.7% following the FDA's priority review for its depression medication's expanded indications [1] Group 2 - Warner Bros. Discovery shares fell by 0.6% as the company plans to reject Paramount - Lionsgate's acquisition offer [1] - Hyatt Hotels shares declined by 1.6% after the company lowered its earnings outlook for 2025 [1]
美股科技股多数上涨,这一股涨超50%
Di Yi Cai Jing Zi Xun· 2025-12-26 15:07
Group 1 - Technology stocks mostly rose, with SanDisk up over 3%, Micron Technology and NVIDIA both rising nearly 1% [1] - Chinese concept stocks showed mixed performance, with the Nasdaq Golden Dragon China Index up 0.2%, while Bawang Chaji fell over 8% and Dingdong Maicai rose over 5% [1] - Biohaven dropped over 10% following the failure of its mid-stage trial for a depression drug [1] - Space concept stock Sidus Space opened up over 30%, briefly rising over 50%, and currently up nearly 45% [1] Group 2 - On December 26, the three major U.S. stock indices opened mixed, with the Dow Jones down 0.02%, the Nasdaq up 0.13%, and the S&P 500 up 0.09% [2]
美股开盘丨三大指数涨跌不一 矿业股普涨
Xin Lang Cai Jing· 2025-12-26 14:57
Group 1 - The Dow Jones Industrial Average fell by 0.04%, while the Nasdaq increased by 0.1% and the S&P 500 rose by 0.08% [1] - Technology stocks mostly saw gains, with SanDisk rising over 3%, and Micron Technology and NVIDIA both increasing by nearly 1% [1] - Mining stocks experienced broad gains, with Coeur Mining rising over 3% and Pan American Silver increasing by nearly 2% [1] Group 2 - Biohaven Pharmaceuticals saw a significant decline of over 10% following the failure of its mid-stage trial for a depression drug [1]
美股科技股多数上涨,这一股涨超50%
第一财经· 2025-12-26 14:55
Market Overview - On December 26, US stock indices opened mixed, with the Dow Jones down 0.02%, the Nasdaq up 0.13%, and the S&P 500 up 0.09% [1] - Current prices are as follows: Dow Jones Industrial Average at 48721.40 (-9.76, -0.02%), Nasdaq Index at 23644.39 (+31.08, +0.13%), S&P 500 at 6938.13 (+6.08, +0.09%) [2] Sector Performance - Technology stocks mostly rose, with SanDisk increasing over 3%, and Micron Technology and NVIDIA both rising nearly 1% [3] - Chinese concept stocks showed mixed performance, with the Nasdaq China Golden Dragon Index up 0.2%. Notable movements include Bawang Tea Jiji down over 8% and Dingdong Maicai up over 5% [4] Company-Specific News - Biohaven experienced a decline of over 10% due to the failure of its mid-stage trial for a depression drug [5] - Space concept stock Sidus Space opened over 30% higher, reaching a peak increase of over 50%, and is currently up nearly 45% [6]
美股三大指数开盘涨跌不一,科尔黛伦矿业涨3.2%
Mei Ri Jing Ji Xin Wen· 2025-12-26 14:40
Market Overview - The U.S. stock market opened mixed on December 26, with the Dow Jones index down by 0.02%, while the S&P 500 and Nasdaq Composite indices both increased by 0.09% [1] Mining Sector - Mining stocks experienced a general increase, with Coeur Mining rising by 3.2%, Pan American Silver up by 3.68%, and Hecla Mining gaining 2.6% [1] E-commerce Sector - South Korean e-commerce company Coupang saw a significant rise of 7.6% after identifying the perpetrator behind a data leak and recovering the involved equipment [1] Pharmaceutical Sector - Biohaven Pharmaceuticals experienced a decline of 10.0% due to its depression drug failing to meet key mid-stage trial objectives [1]
美股盘前丨美股指期货涨跌不一 矿业股盘前普涨
Xin Lang Cai Jing· 2025-12-26 13:53
Company News - Xpeng Motors officially enters the Qatar market and has established a strategic partnership with a dealer in Mauritius [1] - Toyota plans to exceed a global production of 10 million vehicles by 2026 [1] - Biohaven's stock fell over 11% in pre-market trading after its depression drug failed in mid-stage trials [1] Market Dynamics - U.S. stock index futures showed mixed results, with Dow futures down 0.08%, S&P 500 futures down 0.01%, and Nasdaq futures up 0.06% [1] - Spot silver surged over 5% to reach a new high, with a current increase of 3.8%, priced at $74.53 per ounce [1] - U.S. mining stocks saw pre-market gains, with Coeur Mining up 3.5%, Pan American Silver up 3.2%, Hecla Mining up 3.07%, Newmont Mining up 1.2%, and Kinross Gold up 1.09% [1]
美股前瞻 | 三大股指期货涨跌不一,投资者关注“圣诞老人行情”会否继续
智通财经网· 2025-12-26 12:45
Market Overview - US stock market indices reached historical highs before the Christmas holiday, with the S&P 500 closing at 6932.05 points, up 0.3%, the Dow Jones Industrial Average at 48731.16 points, up 0.6%, and the Nasdaq Composite at 23,613.31 points, up 0.2% [2] - The market is currently experiencing low trading volumes, and investors are watching for the continuation of the "Santa Claus rally" [2] 2026 Market Predictions - Wall Street analysts predict the S&P 500 index will reach between 7100 and 8100 points by 2026, with an average target of 7490 points, indicating an approximately 8% upside from current levels [3] - The anticipated growth is driven by the AI boom and potential interest rate cuts from the Federal Reserve, alongside expected corporate earnings growth [3] - However, concerns about inflation, high valuations, and trade tensions could lead to market corrections [3] Gold and S&P 500 Predictions - Ed Yardeni, a prominent market analyst, forecasts that both the S&P 500 index and gold prices could reach 10,000 points and $10,000 per ounce, respectively, by the end of the decade [4] Individual Stock Movements - The global precious metals market has rebounded, with silver prices rising 5% to $75.39 per ounce, marking a historical high, and gold reaching $4530 [5] - Mining stocks saw pre-market gains, with notable increases in companies like Coeur Mining (CDE.US) up 2.72% and First Majestic Silver (AG.US) up 2.67% [5] - Biohaven Pharmaceuticals (BHVN.US) shares fell nearly 16% after its experimental depression drug failed to meet mid-stage trial goals [5] - Waymo, Google's autonomous driving division, temporarily suspended services in San Francisco due to flood warnings [6] - Analyst Dan Ives set a target price of $250 for Nvidia (NVDA.US), citing the company's significant potential in the AI sector [6] - Xpeng Motors (XPV.US) officially entered the Mauritius market, following its expansion into Qatar [6]